Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.28B | 14.54B | 14.66B | 14.85B | 12.52B | 10.58B | Gross Profit |
5.04B | 5.34B | 5.67B | 5.79B | 5.14B | 4.36B | EBIT |
4.93B | 5.25B | 5.56B | 6.02B | 5.59B | 4.36B | EBITDA |
6.72B | 7.07B | 7.34B | 7.39B | 6.65B | 5.76B | Net Income Common Stockholders |
3.24B | 3.47B | 3.71B | 4.17B | 3.78B | 2.77B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.15B | 1.00B | 1.44B | 2.09B | 2.32B | 3.13B | Total Assets |
43.20B | 42.76B | 42.41B | 41.91B | 40.53B | 39.79B | Total Debt |
19.61B | 18.99B | 19.09B | 18.05B | 16.37B | 16.70B | Net Debt |
18.48B | 18.06B | 17.74B | 16.09B | 14.13B | 13.58B | Total Liabilities |
31.02B | 30.26B | 30.27B | 29.29B | 27.03B | 26.68B | Stockholders Equity |
12.18B | 12.51B | 12.13B | 12.63B | 13.50B | 13.11B |
Cash Flow | Free Cash Flow | ||||
2.69B | 2.72B | 3.27B | 3.49B | 3.31B | 2.64B | Operating Cash Flow |
5.42B | 5.25B | 5.55B | 5.62B | 5.10B | 4.26B | Investing Cash Flow |
-2.75B | -2.60B | -2.29B | -2.13B | -1.88B | -649.00M | Financing Cash Flow |
-3.01B | -3.06B | -3.87B | -3.77B | -4.11B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $54.99B | 14.41 | 14.74% | 2.40% | 0.34% | -8.45% | |
75 Outperform | $55.48B | 16.81 | 24.52% | 2.19% | 0.70% | 135.08% | |
74 Outperform | $36.20B | 32.11 | 26.59% | 0.62% | -2.63% | -6.12% | |
73 Outperform | $58.63B | 18.66 | 26.13% | 1.56% | -2.39% | -7.80% | |
71 Outperform | $85.80B | 14.78 | 35.96% | 6.44% | 1.30% | -0.76% | |
68 Neutral | $14.69B | 26.88 | 13.97% | 1.17% | -3.82% | -12.80% | |
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% |
On May 7, 2025, CSX Corporation held its Annual Meeting of Shareholders where twelve directors were elected to the board. Additionally, shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 and approved, on a non-binding basis, the compensation of CSX’s named executive officers.
The most recent analyst rating on (CSX) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on CSX stock, see the CSX Stock Forecast page.
Spark’s Take on CSX Stock
According to Spark, TipRanks’ AI Analyst, CSX is a Outperform.
CSX demonstrates strong financial health with solid profitability and cash flow management. However, recent earnings challenges, revenue decline, and bearish technical indicators weigh on the stock. The moderate valuation and positive corporate governance changes provide a balanced outlook.
To see Spark’s full report on CSX stock, click here.